CAS RN: 75695-93-1 | Product Number: I0876
- Isopropyl Methyl 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
- 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester
- 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Isopropyl Methyl Ester
- Isopropyl Methyl 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Purity / Analysis Method||>98.0%(HPLC)|
|Molecular Formula / Molecular Weight||C__1__9H__2__1N__3O__5 = 371.39|
|Physical State (20 deg.C)||Solid|
|Condition to Avoid||Heat Sensitive|
|Reaxys Registry Number||6576633|
|PubChem Substance ID||253659791|
|Merck Index (14)||5240|
|Appearance||Light orange to Yellow to Green powder to crystal|
|Purity(HPLC)||min. 98.0 area%|
|Elemental analysis(Nitrogen)||10.70 to 11.60 %|
|Melting point||167.0 to 171.0 °C|
|Melting Point||169 °C|
|Hazard Statements||H413 : May cause long lasting harmful effects to aquatic life.
|Precautionary Statements||P501 : Dispose of contents/ container to an approved waste disposal plant.
P273 : Avoid release to the environment.
Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in
Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human α1C subunit
Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats
Isradipine - another calcium-channel blocker for the treatment of hypertension and angina
Safety Data Sheet (SDS) Search
The requested SDS is not available.
Please check that the Product Number you have entered is correct.
If your information is correct and you are still not able to view the requested SDS, please Contact Us for more information.